Novo Holdings A/S’s AnaptysBio ANAB Stock Holding History

Novo Holdings A/S’s Portfolio ANAB Stock Details ANAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-1,190,604	Closed	-$41.6M	–	15
2017 Q3	$41.6M	Sell	1,190,604 -1,842,900	-61%	-$49.7M	5.42%	5
2017 Q2	$72.6M	Hold	3,033,504	–	–	8.69%	2
2017 Q1	$84.2M	Buy	+3,033,504	New	+$70.7M	8.96%	2

Other funds holding ANAB

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Novo Holdings A/S's ANAB Position: Q4 2017 in Review

Novo Holdings A/S sold out of AnaptysBio (ANAB) in Q4 2017, closing a stake of 1,190,604 shares — an estimated $41.6M sold.

Novo Holdings A/S first reported a position in ANAB in Q1 2017 and held it in 3 quarters. The position peaked at $84.2M in Q1 2017. 116 funds tracked by Wall St. Rank hold ANAB as of Q4 2017.

Novo Holdings A/S reported no remaining AnaptysBio position as of Q4 2017 after selling out during the quarter.
Novo Holdings A/S sold 1,190,604 AnaptysBio shares in Q4 2017, an estimated $41.6M.
Novo Holdings A/S first reported a position in AnaptysBio in Q1 2017 and held it in 3 quarters.
Novo Holdings A/S's AnaptysBio position peaked at $84.2M in Q1 2017.
116 funds tracked by Wall St. Rank held AnaptysBio as of Q4 2017.

Based on Novo Holdings A/S's 13F filing for Q4 2017, filed 14 Feb 2018.